Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth B Coffelt

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Immunity|April 21, 2016
Revving Up Dendritic Cells while Braking PD-L1 to Jump-Start the Cancer-Immunity Cycle MotorSeth B Coffelt, Karin E de Visser
Trends in Cancer|September 9, 2025
γδT cells and breast cancer: wicked alliesAbhiram Charan Tej Mallu, Seth B Coffelt
Biochimica Et Biophysica Acta|March 10, 2009
Tumor-associated macrophages: effectors of angiogenesis and tumor progressionSeth B Coffelt, Russell Hughes, Claire E Lewis
Nature Reviews. Cancer|June 19, 2019
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancerBruno Silva-Santos, Sofia Mensurado, Seth B Coffelt
Journal of Reproductive Immunology|March 26, 2014
Fibrinogen, an endogenous ligand of Toll-like receptor 4, activates monocytes in pre-eclamptic patientsEbtisam Al-ofi, Seth B Coffelt, Dilly O Anumba
Plos One|August 1, 2012
Monocyte subpopulations from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to Toll-like receptor ligandsEbtisam Al-ofi, Seth B Coffelt, Dilly O Anumba
Nature Reviews. Cancer|June 11, 2016
Neutrophils in cancer: neutral no moreSeth B Coffelt, Max D Wellenstein, Karin E de Visser
British Journal of Cancer|December 2, 2020
Emerging immunotherapies for metastasisSarah C Edwards, Wilma H M Hoevenaar, Seth B Coffelt
Frontiers in Immunology|September 3, 2019
Neutrophil Maturity in CancerJohn B G Mackey, Seth B Coffelt, Leo M Carlin
Nature Reviews. Cancer|July 18, 2008
The role of myeloid cells in the promotion of tumour angiogenesisCraig Murdoch, Munitta Muthana, Seth B Coffelt, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Immunity|April 21, 2016
Revving Up Dendritic Cells while Braking PD-L1 to Jump-Start the Cancer-Immunity Cycle MotorSeth B Coffelt, Karin E de Visser
Trends in Cancer|September 9, 2025
γδT cells and breast cancer: wicked alliesAbhiram Charan Tej Mallu, Seth B Coffelt
Biochimica Et Biophysica Acta|March 10, 2009
Tumor-associated macrophages: effectors of angiogenesis and tumor progressionSeth B Coffelt, Russell Hughes, Claire E Lewis
Nature Reviews. Cancer|June 19, 2019
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancerBruno Silva-Santos, Sofia Mensurado, Seth B Coffelt
Journal of Reproductive Immunology|March 26, 2014
Fibrinogen, an endogenous ligand of Toll-like receptor 4, activates monocytes in pre-eclamptic patientsEbtisam Al-ofi, Seth B Coffelt, Dilly O Anumba
Plos One|August 1, 2012
Monocyte subpopulations from pre-eclamptic patients are abnormally skewed and exhibit exaggerated responses to Toll-like receptor ligandsEbtisam Al-ofi, Seth B Coffelt, Dilly O Anumba
Nature Reviews. Cancer|June 11, 2016
Neutrophils in cancer: neutral no moreSeth B Coffelt, Max D Wellenstein, Karin E de Visser
British Journal of Cancer|December 2, 2020
Emerging immunotherapies for metastasisSarah C Edwards, Wilma H M Hoevenaar, Seth B Coffelt
Frontiers in Immunology|September 3, 2019
Neutrophil Maturity in CancerJohn B G Mackey, Seth B Coffelt, Leo M Carlin
Nature Reviews. Cancer|July 18, 2008
The role of myeloid cells in the promotion of tumour angiogenesisCraig Murdoch, Munitta Muthana, Seth B Coffelt, et al.
Pageof 7